Molecule

2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid

Chemical Information

23 Related Dataset(s) ⌄

Olopatadine; LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 15; R=35000; [M-H]-

Olopatadine; LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 30; R=35000; [M-H]-

Olopatadine; LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 45; R=35000; [M-H]-

Olopatadine; LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 60; R=35000; [M-H]-

Olopatadine; LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 75; R=35000; [M-H]-

Olopatadine; LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+

Olopatadine; LC-ESI-QFT; MS2; CE: 90; R=35000; [M-H]-

Olopatadine; LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+Na]+

Olopatadine; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; HILIC; CE: 10 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; HILIC; CE: 20 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; HILIC; CE: 30 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; HILIC; CE: 40 eV; R=35000; [M+H]+

Olopatadine; LC-ESI-QTOF; MS2; HILIC; CE: 50 eV; R=35000; [M+H]+

Metadata Information

Field	Value
NFDI4Chem Molecule ID	nfdi4chem-mol86753
Source
Alternate Name

Field	Value
No additional information available for this Dataset.

Data-Source Molecule ID	Data-Source
DB00768	drugbank
CHEMBL1189432	chembl
29359369	surechembl
4668	surechembl
25271818	pubchem
5281071	pubchem
D27V6190PM	fdasrs
PD009730	probes_and_drugs
KUFBIW	CCDC
144773	brenda
HMDB0014906	hmdb
DTXSID3023390	comptox
NCT00331500	clinicaltrials
NCT00389025	clinicaltrials
NCT00550550	clinicaltrials
NCT00562159	clinicaltrials
NCT00578331	clinicaltrials
NCT00655109	clinicaltrials
NCT00691665	clinicaltrials
NCT00772304	clinicaltrials
NCT00789555	clinicaltrials
NCT00794144	clinicaltrials
NCT00818805	clinicaltrials
NCT00836485	clinicaltrials
NCT00845195	clinicaltrials
NCT00979615	clinicaltrials
NCT00987272	clinicaltrials
NCT01007253	clinicaltrials
NCT01076439	clinicaltrials
NCT01287338	clinicaltrials
NCT01294969	clinicaltrials
NCT01326858	clinicaltrials
NCT01435460	clinicaltrials
NCT01470118	clinicaltrials
NCT01479374	clinicaltrials
NCT01698814	clinicaltrials
NCT01700192	clinicaltrials
NCT01732757	clinicaltrials
NCT01743027	clinicaltrials
NCT02161146	clinicaltrials
NCT02251613	clinicaltrials
NCT02322216	clinicaltrials
NCT02478398	clinicaltrials
Molport-003-986-254	molport
1986	drugcentral
50002096	bindingdb
The data in this table is sourced from UniChem at EBI.